Product news
The FDA has approved Sucampo Pharmaceuticals' supplemental NDA for Amitiza (lubiprostone) to treat irritable bowel syndrome with constipation in women 18 years of age or older.
The FDA has approved Sucampo Pharmaceuticals' supplemental NDA for Amitiza (lubiprostone) to treat irritable bowel syndrome with constipation in women 18 years of age or older.
Get the most out of
Register for free and enjoy unlimited access to: